LDN212854
LDN-212854 is a novel BMP inhibitor that exhibits substantially greater selectivity for BMP versus the TGF-β type I receptors; possesses a bias towards ALK2 (IC50=1.3 nM) versus ALK1 and ALK3 compared to other inhibitors.
Product Specifications
CAS Number
1432597-26-6
Product Name Alternative
LDN212854 | LDN 212854 | LDN-212854
Purity
>98% (HPLC)
Solubility
DMSO: 81 mg/mL warmed (199.27 mM)
Smiles
C12=C (C3=C4N=CC (C5=CC=C (N6CCNCC6) C=C5) =CN4N=C3) C=CC=C1N=CC=C2
Molecular Formula
C25H22N6
Molecular Weight
406.48
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
5- (6- (4- (piperazin-1-yl) phenyl) pyrazolo[1,5-a]pyrimidin-3-yl) quinoline
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2554-100 1x 100 µL
Cytokeratin 15 (Esophageal Squamous Cell Carcinoma Marker) (KRT15/2554), 0.2mg/mL
Sign In for Pricing
View Details 
BNC042873-100 1x 100 µL
CD50 / ICAM3 (ICAM3/2873R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC043493-500 1x 500 µL
PAI-RBP1 / SERBP1 / SERPINE1 (SERBP1/3493), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC403435-100 1x 100 µL
CELA3B / ELA3B (Pancreatic Function Marker) (rCELA3B/1811), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC043439-500 1x 500 µL
Ornithine Decarboxylase-1 (ODC-1) (rODC1/485), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042906-100 1x 100 µL
CD72 (B Cell Marker) (BU40), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details